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Abstract
Background: Synchronization between the embryonic stage and the uterine
endometrial lining is important in the outcomes of the vitrified-warmed embryo transfer
(ET) cycles.
Objective: The aim was to investigate the effect of the exact synchronization between
the cleavage stage of embryos and the duration of progesterone administration on the
improvement of clinical outcomes in frozen embryo transfer (FET) cycles.
Materials and Methods: 312 FET cycles were categorized into two groups: (A) day-
3 ET after three days of progesterone administration (n = 177) and (B) day-2 or -4 ET
after three days of progesterone administration (n = 135). Group B was further divided
into two subgroups: B1: day-2 ET cycles, that the stage of embryos were less than
the administrated progesterone and B2: day-4 ET cycles, that the stage of embryos
were more than the administrated progesterone. The clinical outcome measures were
compared between the groups.
Results: The pregnancy outcomes between groups A and B showed a significant
differences in the chemical (40.1% vs 27.4%; p = 0.010) and clinical pregnancies (32.8%
vs 22.2%; p = 0.040), respectively. The rate of miscarriage tended to be higher and live
birth rate tended to be lower in group B than in group A. Also, significantly higher rates
were noted in chemical pregnancy, clinical pregnancy, and live birth in group A when
compared with subgroup B2.
Conclusion: Higher rates of pregnancy and live birth were achieved in day-3 ET after
three days of progesterone administration in FET cycles.
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1. Introduction
For implantation and pregnancy establishment,
a normal developing embryo interacts successfully
with a receptive endometrium (1). During
endometrial receptivity, the window of implantation
(WOI) is opened and temporally complex changes,
including the morphological, cytoskeletal,
biochemical, and genetic, take place in the
endometrium (2). WOI is open five days
after exposure to endogenous or exogenous
progesterone and restricted only for two days.
When the embryo reaches the blastocyst stage
and is ready for implantation, the endometrium
should be in WOI phase. Therefore, if there is
no synchronization, the embryo implantation
does not occur (3). The “synchrony” is defined
as when the embryo and the uterus are both
developing at the same rate; so, they will be ready
to cross-talk for a successful implantation (4).
One of the main cause of recurrent implantation
failure is displacement of WOI that causes an
asynchronous between embryo and endometrium
(5).
Cryopreservation of human embryos and
subsequent frozen embryo transfer (FET) has
become the routine practice in modern ART.
Previously, the pregnancy rates following
FET cycles were lower compared to the
fresh embryo transfer (ET) cycles, due to the
suboptimal embryo survival after slow freezing
(6, 7). The cryopreservation methods were
improved by introduction of vitrification, which
increased the cryo-survival rates up to 95% (8,
9). The degree of embryo development and
endometrial synchronization can influence
the chance of embryo implantation in ART
program (10). Although, the pregnancy rate
was enhanced by improving the embryo
quality during FET cycles (11), little is known
about the optimization of the synchronization
between the endometrial receptivity and embryo
developmental stage.
Several randomized trials reported the
effect of the different endometrial preparation
methods on the outcomes of FET cycles (1,
12, 13). The common method of endometrial
preparation for FET cycles is administration
of estrogen until the endometrial thickness of
about 0.8-1.4 cm, then adding progesterone
for the number of days proportional to the
stage of the embryos being transferred (10).
The duration of progesterone therapy is critical
for establishing the WOI. However, this optimal
duration of progesterone administration before
FET has not been established (14). There is
an assumption that after estrogen priming, the
number of days for exposure to progesterone
will affect an appropriate endometrial lining
to support the implantation of the blastocyst.
However, endometrial biopsy in natural cycles
showed over two-days differences between
the histologic dating and the actual day
after ovulation in 5-50% of the patients (15,
16).
Therefore, the aim of this study was
to investigate the effect of ET in different
stages of embryo development after three
days of progesterone administration on
the clinical outcomes in FET cycles. To
the best of our knowledge, this is the first
preliminary investigation comparing the clinical
outcomes of FET in different stages of embryo
development after three days of progesterone
administration.
2. Materials and Methods
2.1. Study design
This study was conducted at the Yazd
Reproductive Sciences Institute, Yazd, Iran.
Page 228 https://doi.org/10.18502/ijrm.v19i3.8570
International Journal of Reproductive BioMedicine Duration of progestin therapy
In this study, patients qualified for elective
FET. Cycles were evaluated between January
2018 and August 2019. A total of 312 elective
FET cycles met the inclusion criteria for this
study. The cycles were included if high-quality
embryos (grades A and B) were transferred.
Egg donation, surrogacy, in vitro maturation,
and blastocyst transfer cycles were excluded.
Cycles were also excluded if the patients
were lost to follow-up regarding the eventual
occurrence of the pregnancy or delivery.
The cycles were categorized based on the
synchronization of the prepared endometrium
and transferred embryo(s) regarding the duration
of progesterone administration and the stage
of the cleavage embryos. So, the cycles were
divided into two groups: (A) day-3 ET after
three days of progesterone administration
(n = 177) and (B) day-2 or -4 ET after three
days of progesterone administration (n =
135). While analyzing, group B was further
divided into two subgroups: B1: day-2 embryo
after three days of progesterone therapy
and B2: day-4 embryo after three days of
progesterone therapy. In all groups, the
endometria were exposed to progesterone for
three days.
2.2. Ovarian stimulation
GnRH antagonist protocol was conducted in
women undergoing stimulation cycles for IVF
or ICSI. Ovarian stimulation with Gonal-f 150
IU (SA Merck Serono, Geneva, Switzerland) was
initiated on day 2 of the cycle subcutaneously
and later 0.25 mg of cetrorelix (Cetrotide; Asta
Medica, Frankfurt, Germany) daily was addedwhen
the leading follicle reached 14 mm in diameter.
Ovulation was routinely triggered with 10,000 IU
HCG.Oocyte retrieval was performed 34-36 hr later
(17).
2.3. Endometrium preparation
The artificial cycles were carried out using
6 mg daily oral estradiol valerate (2 mg,
Aburaihan Co., Tehran, Iran) from the second
day of the menstrual cycle. On days 12-13
of the cycle, ultrasonography was done. The
vaginal progesterone (Cyclogest; Actavis,
UK limited, England) was given 400 mg
twice daily and oral estradiol was continued
when the endometrial thickness was ≥ 8
mm. ET was performed after three days
of progesterone exposure, and on the day
of ET, the fourth vaginal progesterone was
administered. Estradiol valerate and progesterone
supplementations were continued for two
weeks after ET, and if the serum βHCG
was positive, the hormone supplementations
were continued until twelve 12 wk of
gestation.
2.4. Embryo vitrification
The vitrification was done according to Vitrolife
kit (Vitrolife Inc., Gothenburg, Sweden). Briefly,
the embryos were equilibrated into the Vitri 1TM
Cleave solution for 5 min, and in Vitri2TM Cleave
solution for 2 min. finally the embryo were placed
into Vitri 3TM Cleave solution for 30 sec and
loaded on the top of cryotop. The cryotop was
submerged directly to liquid nitrogen and store it.
For warming, the top of cryotop was submerged
to Warm1TM solution and then placed in Warm2
and 3TM. Finally washed in Warm4TM solution and
culture in G1 medium (Vitrolife Inc., Gothenburg,
Sweden).
2.5. Evaluation of embryo morphology
The morphology of the embryos was assessed
at the same time of ET as described elsewhere
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(18). The grade A embryos were with regular
size blastomere, and no fragmentation; grade B,
the embryos withuneven blastomeres and/or
less than 10% fragmentation; grade C, the
embryos with more than 10% fragmentation
but no more than 25% of blastomeres. Embryos
with grades A and B were considered as top
quality embryos
A positive beta hCG test (30-100 mIU/mL;
Monobind Inc., CA, USA) after fourteenth of
ET day was considered positive chemical
pregnancy. If a fetal heart beat was observed
by ultrasonography at the end of the seventh
week of gestation the clinical pregnancy
was considered positive. The chemical and
clinical pregnancy rate was calculated by
dividing the total number of the pregnancies
by the number of transfer. The total number
of clinical pregnancy losses before the 20th
wk of gestation divided by the total number
of clinical pregnancies was defined as the
miscarriage rate. The live birth rate was calculated
the total number of deliver per number of
transfers.
2.6. Ethical considerations
This retrospective cohort study was
approved by the ethics committee of Yazd
Reproductive Sciences Institute (code:
IR.SSU.RSI.REC.1396.10). Patients’ data were
collected confidentially.
2.7. Statistical analysis
Data were analyzed using the statistical
package for the Social Sciences (SPSS,
Version 14, IBM, USA). Quantitative and
qualitative data are presented as Mean ± SD
and percentages, respectively. Mann-Whitney
U-test, independebt t test and the Chi-
square test were applied to the quantitative
and qualitative data, respectively. All tests
were two-tailed, and p < 0.05 considered as
significant.
3. Results
A total of 611 high-quality embryos from 312
FET cycles were transferred. No significant
differences were found in female age and
the cause of infertility between the groups
(Tables I, II). Also, insignificant differences were
seen regarding the number of transferred
embryos between groups A and B (p =
0.800, Table I). In all cycles, there was no
differences in the number of high-quality
transferred embryos between the groups (p
= 0.850). Data also showed that the rates of
chemical and clinical pregnancies between
two groups were significantly different (p =
0.020 and p = 0.040, respectively) (Table I).
In addition, the rates of miscarriage tended
to be higher and delivery rates tended to be
lower in group B (16.6% vs 15.5%, p = 0.800)
than in group A (18.5% vs 27.6%, p = 0.100),
respectively.
For further analysis, the laboratory and
clinical characteristics of FET cycles were
compared between the three groups categorized
according to synchronization of the embryo
stage and prepared endometrium (Table
II). The female age, cause of infertility,
number of embryos transferred, and embryo
quality were matched between the three
groups. Furthermore, the chemical pregnancy,
clinical pregnancy, and live birth rates were
significantly lower in group B2 compared to
group A (p = 0.003, p = 0.010, and p = 0.020,
respectively).
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Table I. The comparison of laboratory and clinical data between the two groups
Variables Group A (n = 177) Group B (n = 135) P-value Odds ratio (95% CI)
Female age (yr)* 29.61 ± 3.9 30.15 ± 4.0 0.200𝑎
Cause of infertility** 0.200𝑏
Male factor 44.1 42.2
Female factor 44.1 38.5
Male and female 9.5 13.4
Unexplained 2.3 5.9





Chemical pregnancy** 71/177 (40.1) 37/135 (27.4) 0.020𝑏 1.77 (1.09–2.87)
Clinical pregnancy** 58/177 (32.8) 30/135 (22.2) 0.0400𝑏 1.7 (1.02–2.85)
Miscarriage rate** 9/58 (15.5) 5/30 (16.6) 0.800𝑏 0.91 (0.27–3.03)
Live birth rate** 49/177 (27.6) 25/135 (18.5) 0.100𝑏 1.68 (97–290)
*Data presented as Mean ± SD. **Data presented as n (%). 𝑎Mann-Whitney test, 𝑏Chi-square test, 𝑐 t test and U-tests.
(A) Day-3 embryo transfer (ET) after three days of progesterone administration. (B) Day-2 or -4 ET after three days of
progesterone administration
Table II. The comparison of laboratory and clinical data between the three groups
Variables Group B1 (n = 96) Group B2 (n = 39) Group A (n = 177) P-value
Female age (yr)∗𝑎 30.1 ± 4 30.26 ± 4 29.61 ± 3.9
31 (20–36) 30 (23–37) 30 (20–37)
0.400
Cause of infertility∗∗𝑏
Male factor 45.8 33.4 44.1
Female factor 36.5 43.6 44.1
Male and female factor 11.5 17.9 9.5
Unexplained 6.2 5.1 2.3
0.300
No. of transferred embryos∗𝑐 1.93 ± 0.3 2.03 ± 0.1 1.96 ± 0.3 0.200
Embryo grade∗∗𝑏
A 20.8 17.9 19.8
B 79.2 82.1 80.2
0.900
Chemical pregnancy∗∗𝑏 29/96 (30.2) 8/39 (20.5) 71/177 (40.1) 0.100
@, #
0.003$












*Data presented as Mean ± SD. **Data presented as n (%). 𝑎Mann–Whitney test, 𝑏Chi-square test, 𝑐 t test and U-tests
(A) Day-3 embryo transfer (ET) after three days of progesterone administration. (B1) Day-2 embryo ET after three days of
progesterone therapy. (B2) Day-4 embryo ET after three days of progesterone therapy
@Difference between B1 and A cycles, #Difference between B1 and B2 transfer cycles, $Difference between B2 and A cycles
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4. Discussion
The optimal method for endometrial preparation
in FET cycles still remains unclear. Some studies
reported natural cycles had better outcomes
following the transfer of day-3 frozen embryos (19,
20). However, Wright and colleagues concluded
that artificial cycles and stimulated cycles had
comparable results about the rates of pregnancy
and live birth (21). Recently, Dong and associates
stated that utilizing monitoring ovulation regimen
is the best method for the determining the day
of ET in natural cycles. They reported that in
these cycles, determining the precise FET timing
by monitoring serum progesterone level after
ovulation is an unsuitable method (22). Also, in
method of hormone preparations, the length of
administration of progesterone was reportedly
different (23). Routinely, in artificial method
for endometrial preparation, the progesterone
supplementation is initiated three days before ET
with the chance of pregnancy up to 40.5% (24, 25).
Our findings also showed a 40.1% pregnancy rate
in cycles in which day-3 embryos were transferred
to endometrium exposed to progesterone for three
days.
According to our search, this is the first
study comparing the clinical outcomes of ET in
different stages of development to three-days
endometrial preparation in artificial FET cycles.
Our results demonstrated a significantly higher
rates of chemical and clinical pregnancies in
group A with respect to the developmental stage
of embryos with the developmental maturation
of endometrium. However, differences in the
miscarriage and live birth rates between the two
groups were not significant with tendency to group
A. Our data showed that the rates of live birth
were approximately 10% higher in group A when
compared to group B. Contrary to our results,
Vijver and colleagues demonstrated no significant
differences in the pregnancy and implantation
rates when day-4 embryos were transferred after
three or five days of progesterone administration
(26). In their study, the stage of embryo was similar,
but in our study the duration of progesterone
administration was similar in patients and stage of
embryo was different between the groups.
While sub-analyzing, our results showed the
higher pregnancy and live birth rates when the
embryos were transferred B1 (day-2 ET) rather than
B2 (day-4 ET). Similar to our data, Van de Vijver
and colleagues found the opposite results, when
the duration of progesterone administration was
shorter than the embryo stage. They demonstrated
a higher early pregnancy loss in FET cycles
when day-4 embryos were transferred on the
third day after the initiation of progesterone
supplementation (26). Sharma and colleagues
compared the clinical outcome between the three-
and four days progesterone supplementation in
day-2 cleavage embryo. Their study showed
progesterone supplementation for three days
correlated with higher pregnancy and implantation
rate (27). Also, Ding and colleagues showed that
the implantation rates of frozen-thawed blastocysts
on day 6 of progesterone administration was better
than day 7 (28). Despite our study, matching
between the stage of embryo and endometrium
was not evaluated in the aforementioned reports.
Prapas and colleagues showed the highest
pregnancy rates when 4- to 8-cells ET was
performed on the fourth or fifth day of
progesterone administration in artificial cycles
in donation cycles (29). In this duration, the days
of progesterone supplementation were more than
days of embryo.
It is suggested that one of the causes of
recurrent implantation failure is displacement of
implantation window (5). The aforementioned
works focused on the number of progesterone
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administration days and not on matching the day
of endometrium and embryo. It is possible that
when embryos were transferred, the endometrium
is not synchronized with embryo. In other words,
the embryo misses the implantation window,
especially in late transfer cycles. It means when
embryo reaches the blastocyst stage in the uterus
and is ready for implantation, the implantation
window has either not started or had already
finished. In this regards, Chimote and colleagues
showed that the synchrony between the stage
of blastocyst transferred and the endometrial
preparedness is important for clinical outcomes.
They determined this synchronization with respect
to the day of menstrual cycle (30). We recently
showed that overnight culture before the transfer
of warmed embryo is not essential for FET cycles
(31). Therefore, our study suggested that at the
time of embryo thawing, attention should be given
to the day of embryo and the number of days of
progesterone administration. The major drawback
of our study was the retrospective design and
limited number of FET cycles. The endometrial
thicknesses of all the patients were recorded as≥ 8
mm. It is not our protocol to measure endometrium
thickness on the ET day. Furthermore, it is
suggested to measure the progesterone levels in
serum for determining the precise synchronization
between endometrium and embryo stage in FET
cycles.
5. Conclusion
Higher rates of pregnancy and live birth
were achieved with day-3 ET after three days
of progesterone administration in FET cycles.
Also, ET of day-4 embryo after three days of
progesterone exposure had a significantly lower
chemical pregnancy, clinical pregnancy, and live
birth.
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